Cytopenia, dysplasia, and monocytosis: A precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature

Clinical Lymphoma, Myeloma and Leukemia

Volumn 11, Issue 3, 2011, Pages 293-297

  Singh, Zeba N ^a   Post, Ginell R ^a   Kiwan, Elias ^a   Maddox, Anne Marie ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Chronic myelomonocytic leukemia; Monocytosis; Myelodysplasia; Myeloproliferative myelodysplastic; WHO classification

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; GEMTUZUMAB; HEMOGLOBIN; JANUS KINASE 2;

ADULT; AGED; ANEMIA; CANCER CYTODIAGNOSIS; CHROMOSOME TRANSLOCATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CYTOPENIA; DISEASE COURSE; FEMALE; GENE MUTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE COUNT; MALE; MONOCYTOSIS; MULTIPLE CYCLE TREATMENT; MUTATIONAL ANALYSIS; MYELOBLAST; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; ONCOGENE N RAS; REFRACTORY ANEMIA WITH EXCESS BLASTS; REVIEW; SURVIVAL RATE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOSIS; CASE REPORT; CHROMOSOME ABERRATION; GENETICS; KARYOTYPING; LEUKOCYTOSIS; MORTALITY; MUTATION; PANCYTOPENIA;

AGED; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; LEUKOCYTOSIS; MALE; MUTATION; MYELODYSPLASTIC SYNDROMES; PANCYTOPENIA;

EID: 80053361893     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2011.03.019     Document Type: Article

References (22)

1. S.H. Swerdlow, E. Campo, and N.L. Harris WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 IARC Press Lyon, France
2. R. Zittoun Annotation: Subacute and chronic myelomonocytic leukaemia: a distinct haematological entity Br J Haematol 32 1976 1 7
3. R. Neuwirtova, K. Mocikova, and J. Musilova Mixed myelodysplastic and myeloproliferative syndromes Leuk Res 20 1996 717 726 (Pubitemid 26388516)
4. S. Rosati, R. Mick, and F. Xu Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome Leukemia 10 1996 20 26 (Pubitemid 26053457)
5. G.M. Rigolin, A. Cuneo, and M.G. Roberti Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization Haematologica 82 1997 25 30 (Pubitemid 28023483)
6. S.A. Wang, G. Tang, and O. Fadare Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification Mod Pathol 21 2008 1394 1402
7. M. Breccia, L. Cannella, and A. Frustaci Chronic myelomonocytic leukemia with antecedent refractory anemia with excess blasts: further evidence for the arbitrary nature of current classification systems Leuk Lymphoma 49 2008 1292 1296 (Pubitemid 352015791)
8. M. Beran, Y. Shen, and F. Onida Prognostic significance of monocytosis in patients with myeloproliferative disorders Leuk Lymphoma 47 2006 417 423 (Pubitemid 43102089)
9. J.M. Bennett, D. Catovsky, and M.T. Daniel Proposals for the classification of the myelodysplastic syndromes Br J Haematol 51 1982 189 199 (Pubitemid 12073508)
10. L.G. Shaffer, M.L. Slovak, and L.J. Campbell ISCN 2009: An International System for Human Cytogenetic Nomenclature (2009): Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature 2009 Karger Basel
11. U. Germing, A. Kundgen, and N. Gattermann Risk assessment in chronic myelomonocytic leukemia (CMML) Leuk Lymphoma 45 2004 1311 1318 (Pubitemid 38701905)
12. U. Germing, N. Gattermann, and C. Strupp Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients Leuk Res 24 2000 983 992
13. U. Germing, C. Strupp, and S. Knipp Chronic myelomonocytic leukemia in the light of the WHO proposals Haematologica 92 2007 974 977 (Pubitemid 350144245)
14. J.W. Vardiman, J. Thiele, and D.A. Arber The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes Blood 114 2009 937 951
15. S.A. Wang, N. Galili, and J. Cerny Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease Am J Clin Pathol 126 2006 789 797 (Pubitemid 44707630)
16. E.S. Jaffe, N.L. Harris, H. Stein World Health Organization of Tumors Pathology and Genetics Tumors of Hematopoietic and Lymphoid Tissues 2001 IARC Press Lyon, France
17. P. Greenberg, C. Cox, and M.M. LeBeau International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 1997 2079 2088 (Pubitemid 27132124)
18. L. Malcovati, and S.D. Nimer Myelodysplastic syndromes: diagnosis and staging Cancer Control 15 Suppl 2008 4 13
19. G. Garcia-Manero, J. Shan, and S. Faderl A prognostic score for patients wth lower risk myelodysplastic syndrome Leukemia 22 2008 538 543 (Pubitemid 351386723)
20. D.P. Steensma, G.W. Dewald, and T.L. Lasho The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes Blood 106 2005 1207 1209 (Pubitemid 41129580)
21. F. Delhommeau, S. Dupont, and V. Della Valle Mutation in TET2 in myeloid cancers N Engl J Med 360 2009 2289 2301
22. O. Kosmider, V. Gelsi-Boyer, and M. Ciudad TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia Haematologica 94 2009 1676 1681